APA

Borin M. T., Barnes C. N., Darpo B., Pendyala S., Xue H. & Bourdet D. L. (20210531). Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. : Clinical pharmacology in drug development.

Chicago

Borin Marie T, Barnes Chris N, Darpo Borje, Pendyala Srikanth, Xue Hongqi and Bourdet David L. 20210531. Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. : Clinical pharmacology in drug development.

Harvard

Borin M. T., Barnes C. N., Darpo B., Pendyala S., Xue H. and Bourdet D. L. (20210531). Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. : Clinical pharmacology in drug development.

MLA

Borin Marie T, Barnes Chris N, Darpo Borje, Pendyala Srikanth, Xue Hongqi and Bourdet David L. Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. : Clinical pharmacology in drug development. 20210531.